Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly

Novo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Novo Nordisk on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in the U.S., becoming the latest drugmaker to make sharp…#novonordiskinc #brooklyn #novonordisk #novolog #novolin #stevealbers #elililly #lilly #sanofi #medicare

Source: Reuters: Health - March 14, 2023 Category: Consumer Health News Source Type: news